Promotora intervention for metabolic and mental health to reduce type 2 diabetes risk: a pilot randomized controlled trial
Abstract The objective of this study was to develop and evaluate a novel behavioral intervention (PRIME2) that integrates evidence-based approaches for reducing diabetes risk and perceived stress. We conducted a pilot randomized controlled trial of the 16-session PRIME2 intervention vs. usual care a...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-12-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-83482-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841559450790395904 |
|---|---|
| author | Maria C. Vargas Joshua B. Katz Azucena Lopez Arturo Carrillo Dyanna L. Gregory Matthew J. O’Brien |
| author_facet | Maria C. Vargas Joshua B. Katz Azucena Lopez Arturo Carrillo Dyanna L. Gregory Matthew J. O’Brien |
| author_sort | Maria C. Vargas |
| collection | DOAJ |
| description | Abstract The objective of this study was to develop and evaluate a novel behavioral intervention (PRIME2) that integrates evidence-based approaches for reducing diabetes risk and perceived stress. We conducted a pilot randomized controlled trial of the 16-session PRIME2 intervention vs. usual care among 40 Spanish-speaking Latinx adults with prediabetes and body mass index (BMI) ≥ 25 kg/m2. The 3-month change in weight and perceived stress were co-primary outcomes. Secondary outcomes were 3-month changes in hemoglobin A1c (HbA1c), blood pressure, and depressive symptoms. Study participants were women (95%) with mean age 49.9 (± 9.3) years, moderate levels of perceived stress, and risk factors for diabetes, including mean BMI 33.3 (± 5.4) kg/m2 and elevated HbA1c [mean 6.0% (± 0.2)]. PRIME2 participants demonstrated significantly greater 3-month weight loss relative to usual care (− 3.7lbs, p = 0.02). Reductions in perceived stress in both study arms were similar. There were no significant differences in secondary outcomes among PRIME2 participants vs. usual care. This pilot trial demonstrates the feasibility and preliminary weight loss effectiveness of the novel PRIME2 intervention, without observing a significant difference in perceived stress between study arms. Future research should include larger randomized samples that enable a definitive evaluation of intervention effects on both metabolic and mental health endpoints. |
| format | Article |
| id | doaj-art-9275ddeeac5e47b7a47a5c0eb79defd3 |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-9275ddeeac5e47b7a47a5c0eb79defd32025-01-05T12:29:53ZengNature PortfolioScientific Reports2045-23222024-12-011411810.1038/s41598-024-83482-5Promotora intervention for metabolic and mental health to reduce type 2 diabetes risk: a pilot randomized controlled trialMaria C. Vargas0Joshua B. Katz1Azucena Lopez2Arturo Carrillo3Dyanna L. Gregory4Matthew J. O’Brien5Institute of Public Health and Medicine, Northwestern University Feinberg School of MedicineDivision of Endocrinology, Diabetes, and Metabolism, University of Illinois College of Medicine at ChicagoInstitute for Policy Research, Northwestern UniversityBrighton Park Neighborhood CouncilDivision of Digestive & Liver Diseases, Metabolism and Molecular Medicine, The University of Texas Southwestern Medical CenterInstitute of Public Health and Medicine, Northwestern University Feinberg School of MedicineAbstract The objective of this study was to develop and evaluate a novel behavioral intervention (PRIME2) that integrates evidence-based approaches for reducing diabetes risk and perceived stress. We conducted a pilot randomized controlled trial of the 16-session PRIME2 intervention vs. usual care among 40 Spanish-speaking Latinx adults with prediabetes and body mass index (BMI) ≥ 25 kg/m2. The 3-month change in weight and perceived stress were co-primary outcomes. Secondary outcomes were 3-month changes in hemoglobin A1c (HbA1c), blood pressure, and depressive symptoms. Study participants were women (95%) with mean age 49.9 (± 9.3) years, moderate levels of perceived stress, and risk factors for diabetes, including mean BMI 33.3 (± 5.4) kg/m2 and elevated HbA1c [mean 6.0% (± 0.2)]. PRIME2 participants demonstrated significantly greater 3-month weight loss relative to usual care (− 3.7lbs, p = 0.02). Reductions in perceived stress in both study arms were similar. There were no significant differences in secondary outcomes among PRIME2 participants vs. usual care. This pilot trial demonstrates the feasibility and preliminary weight loss effectiveness of the novel PRIME2 intervention, without observing a significant difference in perceived stress between study arms. Future research should include larger randomized samples that enable a definitive evaluation of intervention effects on both metabolic and mental health endpoints.https://doi.org/10.1038/s41598-024-83482-5Diabetes preventionPsychological stressPromotorasCommunity health workersHispanic health |
| spellingShingle | Maria C. Vargas Joshua B. Katz Azucena Lopez Arturo Carrillo Dyanna L. Gregory Matthew J. O’Brien Promotora intervention for metabolic and mental health to reduce type 2 diabetes risk: a pilot randomized controlled trial Scientific Reports Diabetes prevention Psychological stress Promotoras Community health workers Hispanic health |
| title | Promotora intervention for metabolic and mental health to reduce type 2 diabetes risk: a pilot randomized controlled trial |
| title_full | Promotora intervention for metabolic and mental health to reduce type 2 diabetes risk: a pilot randomized controlled trial |
| title_fullStr | Promotora intervention for metabolic and mental health to reduce type 2 diabetes risk: a pilot randomized controlled trial |
| title_full_unstemmed | Promotora intervention for metabolic and mental health to reduce type 2 diabetes risk: a pilot randomized controlled trial |
| title_short | Promotora intervention for metabolic and mental health to reduce type 2 diabetes risk: a pilot randomized controlled trial |
| title_sort | promotora intervention for metabolic and mental health to reduce type 2 diabetes risk a pilot randomized controlled trial |
| topic | Diabetes prevention Psychological stress Promotoras Community health workers Hispanic health |
| url | https://doi.org/10.1038/s41598-024-83482-5 |
| work_keys_str_mv | AT mariacvargas promotorainterventionformetabolicandmentalhealthtoreducetype2diabetesriskapilotrandomizedcontrolledtrial AT joshuabkatz promotorainterventionformetabolicandmentalhealthtoreducetype2diabetesriskapilotrandomizedcontrolledtrial AT azucenalopez promotorainterventionformetabolicandmentalhealthtoreducetype2diabetesriskapilotrandomizedcontrolledtrial AT arturocarrillo promotorainterventionformetabolicandmentalhealthtoreducetype2diabetesriskapilotrandomizedcontrolledtrial AT dyannalgregory promotorainterventionformetabolicandmentalhealthtoreducetype2diabetesriskapilotrandomizedcontrolledtrial AT matthewjobrien promotorainterventionformetabolicandmentalhealthtoreducetype2diabetesriskapilotrandomizedcontrolledtrial |